Skip to main navigation

Investors
News Releases
Events & Presentations
Stock Information
Corporate Governance
SEC Filings
IR Resources

News Releases

News Releases

Year

September 5, 2023

Harpoon Therapeutics to Host KOL Event in Person and via Webcast on September 15, 2023

September 5, 2023

Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences in September

August 9, 2023

Harpoon Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

August 3, 2023

Harpoon Therapeutics to Participate in Two Upcoming Investor Conferences in August

August 1, 2023

Harpoon Therapeutics Appoints Haibo Wang as Senior Vice President of Business Development

June 27, 2023

Harpoon Therapeutics Announces Completion of Planned Patient Enrollment in Phase 1 Study of HPN217 in Relapsed/Refractory Multiple Myeloma

May 11, 2023

Harpoon Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update

April 18, 2023

Harpoon Therapeutics Presents Preclinical Results for Novel T Cell Engagers HPN217 and HPN328 at AACR 2023

April 17, 2023

Harpoon Therapeutics Presents Data for New ProTriTAC™ Development Candidates in TROP2- and ITGB6-expressing Solid Tumors at AACR 2023

April 10, 2023

Harpoon Therapeutics to Participate in the Canaccord Horizons in Oncology Conference

Pagination

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Email Alerts

RSS Feeds

Contact IR

Search

© 2023. Harpoon Therapeutics, Inc. All rights reserved.

Search Investor Relations